Skip to Content Facebook Feature Image

Homes.com Report: Home Prices Hold Steady as Sales Drop Sharply and Inventory Expands

Business

Homes.com Report: Home Prices Hold Steady as Sales Drop Sharply and Inventory Expands
Business

Business

Homes.com Report: Home Prices Hold Steady as Sales Drop Sharply and Inventory Expands

2026-11-18 21:32 Last Updated At:21:40

ARLINGTON, Va.--(BUSINESS WIRE)--Nov 18, 2026--

Homes.com, a CoStar Group (NASDAQ: CSGP) leading online residential marketplace, released its October housing market analysis today. The national median sale price was $383,598, down 0.4% from October 2025. Home sales declined 11.7% year over year, while inventory increased 4.8%.

More Images
Change In Sale Prices In Top 40 Markets

Change In Sale Prices In Top 40 Markets

Annual Change In October Sale Prices

Annual Change In October Sale Prices

Sale Prices In October

Sale Prices In October

U.S. Change In Sale Prices In October

U.S. Change In Sale Prices In October

U.S. Sale Prices In October

U.S. Sale Prices In October

U.S. Annual Percent Change In Sale Prices

U.S. Annual Percent Change In Sale Prices

U.S. Annual Change In Sale Prices

U.S. Annual Change In Sale Prices

U.S. Sale Prices

U.S. Sale Prices

Sale Prices and Annual Change

Sale Prices and Annual Change

U.S. Key Indicators By Property Type

U.S. Key Indicators By Property Type

Change In Sale Prices In U.S. States

Change In Sale Prices In U.S. States

Percent Of Markets Nationally With Increasing Sale Prices

Percent Of Markets Nationally With Increasing Sale Prices

U.S. Sale Prices Key Indicators

U.S. Sale Prices Key Indicators

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118695042/en/

Prices hold near year-ago levels even as fewer homes sell

The combination of falling sales and expanding inventory would ordinarily be expected to put more pressure on prices. Instead, the national median price was essentially unchanged from a year ago. That suggests demand remains sufficient to support prices for the homes that are selling, though with mortgage rates above 7% buyers are evaluating their options carefully. Increased inventory gives buyers more choices, while sellers face more competition for the smaller group of buyers ready to sign contracts.

The national picture masks substantial differences among markets. The median sale price increased by 2% or more in 10 of the 40 largest markets. San Francisco saw a 17.7% surge from a year earlier even as sales declined 13%, while Jacksonville recorded a notable 6.1% price increase despite a 14.4% sales decline. By contrast, 9 of the largest markets saw year-over-year price declines of 2% or more, led by Austin at 9.7% and Nashville at 4.1%. Inventory conditions also varied considerably: Seattle had 22.8% more homes for sale than a year ago, while Jacksonville had 9.8% fewer.

Single-family homes showed the greatest price resilience nationally, with their median price down just 0.3% from a year earlier while townhome and condominium prices each declined 1.4%. Sales weakness was broad but greatest among condos, where sales fell 15.1%, compared with declines of 13.5% for townhomes and 11.2% for single-family homes. Inventory increased across all three categories, rising 5.3% for townhomes, 5.0% for single-family homes and 3.6% for condos.

“October’s results tell a more nuanced story than the nearly flat national price number alone would suggest. Sales were down substantially from a year ago even as buyers had more homes to choose from, yet prices barely moved. That suggests demand remains strong, but buyers appear increasingly selective about which homes they choose to purchase,” said Brad Case, Homes.com Chief Residential Economist. “October’s wide variation across markets also suggests that local supply and demand conditions will remain particularly important as buyers, sellers and agents evaluate market opportunities in the months ahead.”

Additional market insights and reports are available at www.homes.com/reports/.

AboutHomes.com

Homes.com is the fastest-growing residential real estate marketplace and a leading destination for homebuyers, sellers, and real estate professionals. A brand of CoStar Group (NASDAQ: CSGP), Homes.com is redefining online real estate by putting agents and homeowners first through a more transparent, agent-friendly marketplace.

Unlike traditional real estate portals, Homes.com is built around a simple principle: Your Listing, Your Lead™. By connecting consumers directly with the listing agent, Homes.com helps agents win more listings, generate more leads and deliver greater value to their clients. Millions of buyers use Homes.com ’s powerful search tools, rich property content, and AI-driven experiences to discover homes and connect with local real estate experts.

Backed by the largest marketing investment in residential real estate, Homes.com has invested $1.25 billion to build nationwide brand awareness, generating more than 100 billion impressions and establishing Homes.com as a household name among consumers. The platform continues to experience rapid growth, with 83 million average monthly unique visitors*, 115% year-over-year growth in organic search traffic, and more than 36,000 Member Agents joining in just two years.

Homes.com Membership gives agents exclusive marketing advantages and unmatched exposure to help grow their businesses. Based on an internal analysis of approximately 11,000 Member Agents, Members earned an average of $36,400 more in commission during their first year of membership. Members win 60% more listings and received five times more leads than non-member agents**.

For more information, visit Homes.com.

*The Homes.com Network, which includes Homes.com, the Apartments Network, and the Land Network, averaged 83 million monthly unique visitors through July 2026, according to Google Analytics.

** This figure represents an average of 11,000 agents who completed one full year of membership and is not a guarantee of future results. Individual results may vary based on market conditions, geographic location, agent activity, and other factors.

About CoStar Group

CoStar Group (NASDAQ: CSGP) is a global leader in commercial real estate information, analytics, online marketplaces, and 3D digital twin technology. Founded in 1986, CoStar Group is dedicated to digitizing the world’s real estate, empowering all people to discover properties, insights, and connections that improve their businesses and lives.

CoStar Group’s major brands include CoStar, a leading global provider of commercial real estate data, analytics, and news; LoopNet, the most trafficked commercial real estate marketplace; Apartments.com, the leading platform for apartment rentals; Homes.com, the fastest-growing residential real estate marketplace; and Domain, one of Australia’s leading property marketplaces. CoStar Group’s industry-leading brands also include Matterport, a leading spatial data company whose platform turns buildings into data to make every space more valuable and accessible; STR, a global leader in hospitality data and benchmarking; Zonda, a leading provider of data, analytics, software, and marketplace solutions for the residential construction industry; Ten-X, an online platform for commercial real estate auctions and negotiated bids; and OnTheMarket, a leading residential property portal in the United Kingdom.

CoStar Group’s websites attracted over 118 million average monthly unique visitors in the second quarter of 2026, serving clients around the world. Headquartered in Arlington, Virginia, CoStar Group is committed to transforming the real estate industry through innovative technology and comprehensive market intelligence. From time to time, we plan to utilize our corporate website as a channel of distribution for material company information. For more information, visit CoStarGroup.com.

Change In Sale Prices In Top 40 Markets

Change In Sale Prices In Top 40 Markets

Annual Change In October Sale Prices

Annual Change In October Sale Prices

Sale Prices In October

Sale Prices In October

U.S. Change In Sale Prices In October

U.S. Change In Sale Prices In October

U.S. Sale Prices In October

U.S. Sale Prices In October

U.S. Annual Percent Change In Sale Prices

U.S. Annual Percent Change In Sale Prices

U.S. Annual Change In Sale Prices

U.S. Annual Change In Sale Prices

U.S. Sale Prices

U.S. Sale Prices

Sale Prices and Annual Change

Sale Prices and Annual Change

U.S. Key Indicators By Property Type

U.S. Key Indicators By Property Type

Change In Sale Prices In U.S. States

Change In Sale Prices In U.S. States

Percent Of Markets Nationally With Increasing Sale Prices

Percent Of Markets Nationally With Increasing Sale Prices

U.S. Sale Prices Key Indicators

U.S. Sale Prices Key Indicators

WALTHAM, Mass.--(BUSINESS WIRE)--Nov 18, 2026--

Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ VaxEvo™ CD 293 Medium, a chemically defined and animal origin-free medium designed to support suspension HEK293 cell growth and high-titer adenovirus production. Available in liquid and AGT™ formats, the medium is designed to support vaccine developers from early process development through scale-up and manufacturing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118289303/en/

As suspension-based HEK293 workflows evolve to support scalable adenoviral vectors and adenovirus vaccine production, developers need media that can help deliver strong productivity while reducing process complexity and supporting manufacturing readiness. VaxEvo CD 293 Medium is designed to address these evolving needs.

“Manufacturing readiness begins well before a process reaches the plant. The choices vaccine developers make during process development can shape how they evaluate performance, complexity and the path to scale,” said Alex Cherkassky, vice president and general manager of Thermo Fisher Scientific’s cell culture business. “We developed Gibco VaxEvo CD 293 Medium as a purpose-built starting point to help customers advance suspension-based adenovirus HEK293 processes with greater confidence.”

In laboratory benchmarking studies using HEK293 cells, VaxEvo CD 293 Medium supported average adenovirus type 5 (Ad5) titers comparable to select supplier media, with results reaching up to 5.7-fold higher titers in some comparisons.

The product will be available in liquid and multiple AGT™ package sizes.

To learn more about the Gibco™ VaxEvo™ CD 293 Medium, please visit thermofisher.com/VaxEvo-CD293-Media.

Frequently Asked Questions

What is Gibco™ VaxEvo™ CD 293 Medium?

A chemically defined, animal origin-free cell culture medium designed to support suspension HEK293 cell growth for adenoviral vectors, adenovirus vaccine, and oncolytic virus production.

Who is it designed for?

Vaccine process development scientists and upstream manufacturing teams at human and animal health vaccine manufacturers using suspension HEK293 cells, particularly for adenovirus-based applications.

What problem does it address?

VaxEvo CD 293 Medium addresses the need for a chemically defined suspension medium that supports robust HEK293 cell growth and adenovirus productivity while reducing process complexity. In benchmarking studies, VaxEvo CD 293 Medium demonstrated comparable or higher titers without a dedicated feed versus select benchmark media used with their recommended feeds.

Why does it matter?

VaxEvo CD 293 Medium combines adenovirus productivity, robust cell growth and process simplicity in a chemically defined, animal origin-free platform available in scalable liquid and AGT™ formats, helping support progression from vaccine process development toward manufacturing.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.

© 2026 Thermo Fisher Scientific Inc. All rights reserved.

All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries unless otherwise specified

Gibco™ VaxEvo™ CD 293 Medium Collection

Gibco™ VaxEvo™ CD 293 Medium Collection

Recommended Articles